Primary Myelofibrosis Recruiting Phase 2 Trials for Cefotaxime (DB00493)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02251821JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary MyelofibrosisTreatment
NCT03303950Busulfan, Fludarabine, Donor Stem Cell Transplant, and Cyclophosphamide in Treating Patients With Multiple Myeloma or MyelofibrosisTreatment